Works matching IS 02724391 AND DT 1990 AND VI 21 AND IP 3
Results: 11
GABA receptors and GABAergic synapses as targets for drug development.
- Published in:
- Drug Development Research, 1990, v. 21, n. 3, p. 151, doi. 10.1002/ddr.430210302
- By:
- Publication type:
- Article
Pharmacology of Cl-966: A potent GABA uptake inhibitor, in vitro and in experimental animals.
- Published in:
- Drug Development Research, 1990, v. 21, n. 3, p. 195, doi. 10.1002/ddr.430210306
- By:
- Publication type:
- Article
Masthead.
- Published in:
- Drug Development Research, 1990, v. 21, n. 3, p. fmi, doi. 10.1002/ddr.430210301
- Publication type:
- Article
Synthesis and metabolic profile of Cl-966: A potent, orally-active inhibitor of GABA uptake.
- Published in:
- Drug Development Research, 1990, v. 21, n. 3, p. 189, doi. 10.1002/ddr.430210305
- By:
- Publication type:
- Article
Initial human safety and tolerance study of a GABA uptake inhibitor, Cl-966: Potential role of GABA as a mediator in the pathogenesis of schizophrenia and mania.
- Published in:
- Drug Development Research, 1990, v. 21, n. 3, p. 235, doi. 10.1002/ddr.430210309
- By:
- Publication type:
- Article
New class of hallucinogens: GABA-enhancing agents.
- Published in:
- Drug Development Research, 1990, v. 21, n. 3, p. 253, doi. 10.1002/ddr.430210311
- By:
- Publication type:
- Article
GABA-A agonists and GABA uptake inhibitors: Structure-activity relationships.
- Published in:
- Drug Development Research, 1990, v. 21, n. 3, p. 169, doi. 10.1002/ddr.430210304
- By:
- Publication type:
- Article
GABAmimetic drugs in hyperkinetic involuntary movement disorders and their effects on mental status.
- Published in:
- Drug Development Research, 1990, v. 21, n. 3, p. 227, doi. 10.1002/ddr.430210308
- By:
- Publication type:
- Article
Assessment of zolpidem and Cl-966 for anxiolytic and anxiogenic properties by using the discrimination of pentylenetetrazole by rats.
- Published in:
- Drug Development Research, 1990, v. 21, n. 3, p. 243, doi. 10.1002/ddr.430210310
- By:
- Publication type:
- Article
Distribution of GABA<sub>A</sub> and GABA<sub>B</sub> receptors in mammalian brain: Potential targets for drug development.
- Published in:
- Drug Development Research, 1990, v. 21, n. 3, p. 161, doi. 10.1002/ddr.430210303
- By:
- Publication type:
- Article
Neuropharmacological evidence for an interaction between the GABA uptake inhibitor Cl-966 and anxiolytic benzodiazepines.
- Published in:
- Drug Development Research, 1990, v. 21, n. 3, p. 217, doi. 10.1002/ddr.430210307
- By:
- Publication type:
- Article